Responses of surface arteries and blood flow of ischemic and nonischemic cerebral cortex to aminophylline, ergotamine tartrate, and acetazolamide.
D000086:Acetazolamide / Q000627:therapeutic use*; D000136:Acid-Base Equilibrium; D000628:Aminophylline / Q000627:therapeutic use*; D000818:Animals; D001784:Blood Gas Analysis; D002245:Carbon Dioxide / Q000097:blood; D002257:Carbonic Anhydrase Inhibitors; D002415:Cats; D002536:Cerebral Arteries / Q000187:drug effects*; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D004878:Ergotamine / Q000627:therapeutic use*; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D013644:Tartrates / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D002257:Carbonic Anhydrase Inhibitors; D013644:Tartrates; D014662:Vasoconstrictor Agents; D002245:Carbon Dioxide; D000628:Aminophylline; D000086:Acetazolamide; D004878:Ergotamine